J. Bevan

402 total citations
12 papers, 277 citations indexed

About

J. Bevan is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, J. Bevan has authored 12 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Cardiology and Cardiovascular Medicine and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in J. Bevan's work include Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Inflammatory mediators and NSAID effects (5 papers) and Hormonal and reproductive studies (2 papers). J. Bevan is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Inflammatory mediators and NSAID effects (5 papers) and Hormonal and reproductive studies (2 papers). J. Bevan collaborates with scholars based in United Kingdom, United States and Germany. J. Bevan's co-authors include David Savage, S P Hanley, Stan Heptinstall, S R Cockbill, Marie L. Smith, I. Fogelman, Eleanor M. Scott, D. M. Hart, Erika Glusa and Christopher J. Hawley and has published in prestigious journals such as Thrombosis and Haemostasis, Calcified Tissue International and Thrombosis Research.

In The Last Decade

J. Bevan

11 papers receiving 258 citations

Peers

J. Bevan

CCM

PHARM

EE

OSM

ONCOL

Michael Breitenstein United States

K. McNeill United Kingdom

Jiaxing Zhang China

Yuquan Xie China

Liangliang Wang China

Shaopeng Liu China

Kohei Tamura Japan

William H. Strain United States

Xiaowei Sun China

Soetkin Van kerckhoven Belgium

Michael Breitenstein United States

J. Bevan

41 ×0.5

CCM

26 ×0.3

PHARM

21 ×0.5

EE

46 ×1.1

OSM

4 ×0.1

ONCOL

Citations per year, relative to J. Bevan J. Bevan (= 1×) peers Michael Breitenstein

Countries citing papers authored by J. Bevan

Since Specialization

Citations

This map shows the geographic impact of J. Bevan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Bevan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Bevan more than expected).

Fields of papers citing papers by J. Bevan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Bevan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Bevan. The network helps show where J. Bevan may publish in the future.

Co-authorship network of co-authors of J. Bevan

This figure shows the co-authorship network connecting the top 25 collaborators of J. Bevan. A scholar is included among the top collaborators of J. Bevan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Bevan. J. Bevan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Hawley, Christopher J., et al.. (2000). Coadministration therapy with reboxetine and serotonin specific reuptake inhibitors in twenty-four patients with major depression. European Neuropsychopharmacology. 10. 231–231. 7 indexed citations

2.

Smith, Marie L., et al.. (1989). Effect of etidronate disodium on bone turnover following surgical menopause. Calcified Tissue International. 44(2). 74–79. 42 indexed citations

3.

Glusa, Erika, J. Bevan, & Stan Heptinstall. (1989). Verapamil is a potent inhibitor of 5-HT-induced platelet aggregation. Thrombosis Research. 55(2). 239–245. 8 indexed citations

4.

Bevan, J. & David Savage. (1989). The effect of organic acids on the dissolution of K-feldspar under conditions relevant to burial diagenesis. Mineralogical Magazine. 53(372). 415–425. 91 indexed citations

5.

Heptinstall, S & J. Bevan. (1988). How can we inhibit 5-HT-induced platelet aggregation and why should we bother?. PubMed. 115(4). 475–8. 1 indexed citations

6.

Gunness-Hey, M., Janet M. Hock, István Gera, et al.. (1986). Human parathyroid hormone (1–34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25 dihydroxyvitamin D3. Calcified Tissue International. 38(4). 234–238. 8 indexed citations

7.

Hanley, S P & J. Bevan. (1985). Inhibition by aspirin of human arterial and venous prostacyclin synthesis. Prostaglandins Leukotrienes and Medicine. 20(2). 141–149. 6 indexed citations

8.

Hanley, S P, J. Bevan, S R Cockbill, & Stan Heptinstall. (1982). A regimen for low-dose aspirin?. BMJ. 285(6351). 1299–1302. 42 indexed citations

9.

Hanley, S P, J. Bevan, S R Cockbill, & Stan Heptinstall. (1981). The Effect Of Low Dose Aspirin On Human Venous Prostacyclin Production And Platelet Thromboxane Synthesis. Thrombosis and Haemostasis. 2 indexed citations

10.

Heptinstall, Stan, J. Bevan, S R Cockbill, et al.. (1981). Inhibition Of Thromboxane Synthesis And Of Arachidonate- Induced Platelet Behaviour In Platelets From Different Individuals. Thrombosis and Haemostasis. 2 indexed citations

11.

Heptinstall, Stan, et al.. (1980). Effects of a selective inhibitor of thromboxane synthetase on human blood platelet behaviour. Thrombosis Research. 20(2). 219–230. 67 indexed citations

12.

Adams, John H., et al.. (1978). An automatic six-channel aggregometer to measure blood platelet or crystal aggregation [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 276. 16P–17P. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact